-
Part 4 | Session 1 Dr Lim: Patient Care and Finding Your Passion
-
Part 4 | Session 3 Dr Sorajja: Why He Chose Cardiovascular Medicine
-
Part 1 | Session 1 EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
-
Part 1 | Session 2 BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction
-
Part 1 | Session 4 TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation
-
Part 1 | Session 5 EBC MAIN Three-Year Follow Up
-
Part 1 | Session 6 TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock
-
Part 1 | Session 7 FAME III Three-Year Follow-Up
-
Part 2 | Session 1 View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Learn the key take-home messages from EuroPCR 2023 with View from the Thoraxcenter hosts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this dynamic video review, Dr Daemen and Prof Van Mieghem cover the top late-breaking science, offering insight into how they will incorporate the data into their clinical practice.
What are the top trials of EuroPCR 2023? What are the considerations for practice? What is next?
00:44: EBC TWO 5-Year Follow-Up
00:59: EBC Main 3-Year Follow-Up
01:33: KISS Trial
03:53: Repeat TAVR
05:24: Chimney Stenting vs BASILICA to Prevent TAVR-related Coronary Obstruction
08:36: Prospective MITRAL Trial
10:05: DRAGONFLY-DMR
11:32: FAST-TAVI II
13:57: EUROSHOCK
17:01: REFORM
18:30: TRANSFORM I
20:02: BIOMAG-1
22:15: ABSORB IV
23:38: DEFINE-FLAIR
25:31: FAME III
26:59: SMART
Get a critical review of the EuroPCR 2023 late-breaking and featured data!
Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.
Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023.
More from this programme
Part 1
Expert Interviews
Short, concise overviews of the key data revealed at EuroPCR 2023, focussing on the results and impact on future research.
Part 2
View from the Thoraxcenter
In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023.
Part 3
Highlights Reviews
Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.
Part 4
Behind the Heart
Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.
Faculty Biographies
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Nicolas M Van Mieghem
Full Professor of Interventional Cardiology
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
Academic History
Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…
Comments